Quilizumab
Quilizumab (Anti-Human IGHE Recombinant Antibody) is a humanized IgG1κ monoclonal antibody targeting immunoglobulin epsilon (also konwn as: IGHE, IgE) . Quilizumab targets the M1-prime fragment of membrane-expressed IGHE/IgE, leading to IGHE/IgE switching and memory B cell depletion. Quilizumab has potential in asthma research[1].
Product Specifications
CAS Number
[1228538-47-3]
Product Name Alternative
Anti-Human IGHE Recombinant Antibody
UNSPSC
12352203
Target
Apoptosis
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/quilizumab.html
Purity
99.83
Solubility
H2O
Smiles
[Quilizumab]
Molecular Weight
(146.5 kDa)
References & Citations
[1]Jeffrey M Harris, et al. A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma. Respir Res. 2016 Mar 18;17:29.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
246986-PE 100 µL
HDHD1A (Haloacid Dehalogenase-like Hydrolase Domain Containing 1A, DXF68S1E, FAM16AX, GS1) (PE)
Ask
View Details 